Is prophylactic administration of steroids of benefit to children undergoing cardiac surgery?

Muneer Amanullah1, Asif Hasan, Jo Roe

  • 1Department of Cardiothoracic Surgery, Freeman Hospital, Freeman Road, Newcastle upon Tyne NE7 7DN, UK. mmamanullah@doctors.org.uk

Insights

Prophylactic steroids may benefit children undergoing cardiac surgery by reducing inflammatory markers and potentially improving clinical outcomes. Further research is needed to confirm these benefits for pediatric cardiac surgery patients.

Area of Science:

  • Pediatric Cardiac Surgery
  • Pharmacology
  • Critical Care Medicine

Background:

  • Cardiac surgery in children can lead to significant inflammatory responses.
  • The use of prophylactic steroids is a potential strategy to mitigate these responses.

Purpose of the Study:

  • To evaluate the evidence for the benefit of prophylactic steroid administration in children undergoing cardiac surgery.
  • To assess the impact of steroids on biochemical markers and clinical outcomes.

Main Methods:

  • A systematic review of the literature was conducted.
  • Thirty-two papers were identified, with six representing the best evidence.
  • Data on patient groups, study types, outcomes, and results were tabulated.

Main Results:

  • Steroids may reduce Troponin I release, C-reactive protein (CRP), and Interleukin-6 levels.
  • Limited evidence suggests potential improvements in Intensive Care Unit (ICU) stay and fluid requirements.
  • These findings were based on a small number of patients in two studies.

Conclusions:

  • Prophylactic steroids show promise in reducing inflammatory markers post-pediatric cardiac surgery.
  • Clinical benefits require confirmation through larger, robust studies before widespread recommendation.
  • Further investigation is warranted to establish definitive clinical advantages.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...